Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors

NCT01454804 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancers

Interventions

DRUG: Pazopanib
DRUG: Lapatinib
DRUG: Trastuzumab (Herceptin®)
DRUG: Pazopanib

Sponsor

M.D. Anderson Cancer Center